Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$3.54 - $8.35 $1.38 Million - $3.25 Million
389,468 Added 78.29%
886,925 $6.51 Million
Q4 2023

Feb 14, 2024

BUY
$1.65 - $3.94 $789,124 - $1.88 Million
478,257 Added 2490.92%
497,457 $1.86 Million
Q3 2023

Nov 14, 2023

BUY
$2.02 - $5.04 $38,784 - $96,768
19,200 New
19,200 $40,000
Q4 2022

Feb 14, 2023

BUY
$9.86 - $23.83 $533,859 - $1.29 Million
54,144 Added 63.81%
139,000 $1.4 Million
Q3 2022

Nov 14, 2022

SELL
$21.04 - $36.06 $331,085 - $567,440
-15,736 Reduced 15.64%
84,856 $1.9 Million
Q2 2022

Aug 15, 2022

BUY
$17.78 - $42.39 $1.79 Million - $4.26 Million
100,592 New
100,592 $2.49 Million
Q1 2021

May 17, 2021

SELL
$72.16 - $117.4 $297,082 - $483,335
-4,117 Closed
0 $0
Q4 2020

Feb 16, 2021

SELL
$38.09 - $100.95 $190,297 - $504,346
-4,996 Reduced 54.82%
4,117 $375,000
Q3 2020

Nov 16, 2020

BUY
$30.41 - $40.5 $277,126 - $369,076
9,113 New
9,113 $0
Q4 2019

Feb 14, 2020

SELL
$13.39 - $20.73 $1.29 Million - $2 Million
-96,400 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$15.47 - $22.5 $1.32 Million - $1.91 Million
85,035 Added 748.22%
96,400 $1.5 Million
Q2 2019

Aug 14, 2019

BUY
$15.61 - $20.44 $177,407 - $232,300
11,365 New
11,365 $231,000
Q4 2018

Feb 14, 2019

SELL
$11.48 - $16.98 $1.33 Million - $1.97 Million
-116,100 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$8.75 - $16.29 $1.02 Million - $1.89 Million
116,100 New
116,100 $1.89 Million

Others Institutions Holding FATE

About FATE THERAPEUTICS INC


  • Ticker FATE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,000,304
  • Market Cap $161M
  • Description
  • Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...
More about FATE
Track This Portfolio

Track Schonfeld Strategic Advisors LLC Portfolio

Follow Schonfeld Strategic Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.